Primary cytomegalovirus (CMV) infections or those resulting from reactivation of latent virus causes severe morbidity and mortality in the immunocompromised host, including bone marrow transplant recipients inflicted with various forms of leukemia. Monocyte/macrophage tropism is central to CMV pathogenesis because this cell type disseminates virus, supports productive infection, and harbors latent CMV DNA. Unique CMV-macrophage interactions have evolved to preserve this relationship and guarantee survival of the virus within the host. The long-term goal of this project is to identify the function of CMV gene products that regulate monocyte/macrophage tropism. Using the mouse model of CMV pathogenesis, two US22 family members genes, M140 and M141, have been identified as determinants of macrophage tropism. The products of these two genes (pM140 and pM141) form a complex within the infected cell, and deletion of either gene attenuates growth of murine CMV (MCMV) in macrophages and the macrophage-rich environment of the spleen. The hypothesis of the proposed research is that pM140 functions both independently and as a defined, structural complex with pM141 to regulate downstream events in MCMV replication critical for efficient growth of the virus in the cellular environment of the macrophage. The specific objectives of this proposal are to 1) characterize the pM140/ pM141 complex with respect to structural components and stoichiometry, 2) identify the protein domains that facilitate pM140and pM141 complex formation, 3) determine the role of pM140 and the pM140/pM141 complex in MCMV pathogenesis, and 4) identify the molecular mechanisms of how these proteins function to confer macrophage tropism. Understanding the mechanisms of how MCMV replication is regulated in macrophages is crucial to understanding a key step in viral pathogenesis. The ability to manipulate replication of CMV in this cell type would afford opportunities to control the diseases that often manifest as a consequence of acute or reactivated CMV infections. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA041451-14A2
Application #
6683086
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Daschner, Phillip J
Project Start
1996-08-01
Project End
2008-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
14
Fiscal Year
2003
Total Cost
$295,677
Indirect Cost
Name
Eastern Virginia Medical School
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
058625146
City
Norfolk
State
VA
Country
United States
Zip Code
23501
Bolin, Lisa L; Hanson, Laura K; Slater, Jacquelyn S et al. (2010) Murine cytomegalovirus US22 protein pM140 protects its binding partner, pM141, from proteasome-dependent but ubiquitin-independent degradation. J Virol 84:2164-8
Hanson, Laura K; Slater, Jacquelyn S; Cavanaugh, Victoria J et al. (2009) Murine cytomegalovirus capsid assembly is dependent on US22 family gene M140 in infected macrophages. J Virol 83:7449-56
Campbell, Ann E; Cavanaugh, Victoria J; Slater, Jacquelyn S (2008) The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol 197:205-13
Cavanaugh, Victoria J; Raulet, David H; Campbell, Ann E (2007) Upregulation of CD94/NKG2A receptors and Qa-1b ligand during murine cytomegalovirus infection of salivary glands. J Gen Virol 88:1440-5
Child, Stephanie J; Hanson, Laura K; Brown, Crystal E et al. (2006) Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. J Virol 80:10173-80
Karabekian, Zaruhi; Hanson, Laura K; Slater, Jacquelyn S et al. (2005) Complex formation among murine cytomegalovirus US22 proteins encoded by genes M139, M140, and M141. J Virol 79:3525-35
Ciocco-Schmitt, Gina M; Karabekian, Zaruhi; Godfrey, Earl W et al. (2002) Identification and characterization of novel murine cytomegalovirus M112-113 (e1) gene products. Virology 294:199-208
Hanson, L K; Slater, J S; Karabekian, Z et al. (2001) Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen. J Virol 75:6292-302
Hanson, L K; Slater, J S; Karabekian, Z et al. (1999) Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol 73:5970-80
Jones, T R; Hanson, L K; Sun, L et al. (1995) Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 69:4830-41